What CNO Financial Group stock’s recent moves tell you

CNO Financial Group (CNO) has attracted fresh attention after recent share price moves, with the stock closing at $45.90 and showing double digit total return over the past year.

The recent 10.1% 1 month share price return and 8.8% year to date share price return suggest positive momentum is building. The 1 year total shareholder return of 23.9% and 3 year total shareholder return of about 13x indicate longer term holders have already seen strong gains.

If CNO Financial Group’s momentum has you reviewing your watchlist, this can be a good time to broaden your search and uncover 19 top founder-led companies

With CNO trading at $45.90, about 3% below the average analyst price target of $47.50 and an estimated 25% intrinsic discount, an important question is whether there is still a buying opportunity here or whether the market is already pricing in future growth.

Most Popular Narrative: 20% Undervalued

Compared with CNO Financial Group’s last close at $45.90, the most followed narrative points to a fair value of $46, implying a modest discount despite recent share price strength.

Accelerating growth in annuity and life/health policy sales, particularly driven by a rapidly aging U.S. population (11,000 Americans turning 65 each day) and increased focus on retirement income solutions, is expanding CNO's addressable market and supporting consistent, repeatable revenue gains.

Want to see what is sitting behind that growth story, and how it links to higher margins, rising earnings, and a lower future P/E multiple? The most followed narrative spells out the revenue path, the profit assumptions, and the share count changes that need to line up for today’s price to meet those expectations.

Result: Fair Value of $46 (UNDERVALUED)

However, you also need to weigh risks, including pressure on investment income if interest rates fall and potential margin strain if long term care claims rise.

Another Way To Look At CNO’s Valuation

The earlier view leans on future cash flows and suggests CNO is 25.4% below an estimate of fair value. On the other hand, the P/E of 17.5x sits above both the estimated fair ratio of 15.1x and the US Insurance industry average of 11.4x, which points to valuation risk if sentiment cools.

That mix of discount to fair value and premium P/E raises a simple question: which signal do you treat as more important for your own process, the cash flow model or the market multiple?

Next Steps

With both risks and rewards on the table, do you think the current confidence in CNO is justified or stretched, and what does the data tell you when you look at it directly and compare the 3 key rewards and 3 important warning signs

Looking for more investment ideas?

If CNO has sharpened your focus, do not stop here. Widen your opportunity set with a few targeted stock ideas built from clear fundamentals and risk profiles.

• Target consistent compounding by reviewing companies screened as 12 dividend fortresses, helping you focus on income opportunities that align with your risk tolerance.
• Pursue value by scanning 51 high quality undervalued stocks that combine quality metrics with pricing that could appeal to long term investors.
• Prioritise resilience by checking 72 resilient stocks with low risk scores so you are not left on the sidelines if quality, lower volatility stocks start to attract more attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.